Stablecoins’ “next battleground is in emerging markets,” one expert said, as Circle looks to expand USDC’s reach where rival Tether has long been strong. Source link
GE HealthCare is said to near $1B Sofie Biosciences deal
GE HealthCare is said to near $1B Sofie Biosciences deal Source link
Crypto's Clarity Act is a Schrödinger's cat in life-death limbo as U.S. Senate returns
The crypto industry eagerly awaits a September 15 vote, though it might not happen. Or maybe it will. Or it might get delayed or reappear in some other form. Source link
This dull FTSE 100 stock has profits SpaceX can only dream of – and an index-thrashing dividend yield!
Image source: Getty Images I understand why so many investors have got excited about SpaceX stock in recent months. There is a brilliant story to the business and it is growing at a rate of knots. Bonus is activities like rocket launches and landings are both spectacular and capture the…
How to Negotiate Salary When They Say No (7-Step Playbook)
Hearing “no” on a compensation request isn’t a dead end—it’s market intelligence you can exploit. Walking away empty-handed happens only when you confuse emotion with leverage and fail to target the budgets sitting right outside standard HR payroll. Use this field-tested 7-step blueprint to audit your errors, extract non-salary compensation,…
The P/E ratio on Nvidia stock has fallen to 14. Time to consider buying?
Nvidia (NASDAQ: NVDA) stock looks really cheap at the moment. Currently, it’s sporting a forward-looking, price-to-earnings (P/E) ratio of just 14.2 – well below the US market average. Is it time to consider buying the AI chip stock if you don’t own it (or more of it if you do)?…
Could the Taylor Wimpey share price climb to 110p by September 2027?
If Taylor Wimpey‘s (LSE: TW) share price was a house, the roof would have fallen in. It’s plunged 55% over five years and 20% over the last 12 months. That understates the pain investors have suffered. At around 77p, the FTSE 250 housebuilder is trading at similar levels to 13…
Down 18% in a month! Is this UK growth share now a better buy than Rolls-Royce or BAE Systems?
One high-flying UK growth share has again caught my eye. I’ve been tracking its progress for a year, looking for an opportunity to buy it at a more sensible valuation. It’s just fallen 18% in a month. Is this it? The stock’s FTSE 100 defence specialist Babcock International Group (LSE:…
Sh*t Recruiters Say: It’s a Work Hard, Play Hard Culture #shorts
Sh*t Recruiters Say: It’s a Work Hard, Play Hard Culture #shorts By Jeff Altman, The Big Game Hunter Let me decode this for you so that you’re not confused by what they’re really telling you. Increase Your Chances of Getting a Response to Your Application ABOUT JEFF ALTMAN, THE BIG…
On P/Es of just 5 and 7, these UK dividend stocks look cheap as chips
Many UK stocks continue to appear deeply undervalued to me. But don’t take my word for it, just look at the companies that have been snapped up at sizeable premiums this year: Spire Healthcare, Intertek, easyJet, and others. Here are a pair of UK shares trading at very low forward-looking…